We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aortech International Plc | LSE:AOR | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 126.50 | 123.00 | 130.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/2/2018 10:44 | May as well have given them to Oxfam.... (10 shares not the 15k!) | semper vigilans | |
13/2/2018 10:43 | morning all i agree the 15k was a buy | petebarnes1 | |
13/2/2018 10:41 | Someone flogged 10 shares so that's the MM's reloaded ;) | bones | |
13/2/2018 10:18 | Yes it was a friend of mine who bought the 15k yesterday. I spoke to him this morning he did very well to purchase at that price IMHO | parsons4 | |
13/2/2018 09:53 | FYI - that’s a buy as was the 15k yesterday ;-) | turbotrader2 | |
13/2/2018 08:47 | Volume is only tiny coz there isn’t any stock to play with! That will change | turbotrader2 | |
13/2/2018 07:31 | MagC. wasting your time trying to engage the ramping idiot, who has posted almost 23 thousand times since June 14. His attitude to anyone who has a different opinion or even a view on how things may play out, is shocking. | cocker | |
12/2/2018 23:53 | Well, there have been discussions in past RNS's about raising the necessary finance (from potential partners rather than AOR) to progress the trialling of AOR's work on the polymer heart valve. I have always gained the impression that AOR have an eye on more than just licensing in this field.Given the recent clearing up of legal disputes over the ex-CEO and his involvement with the heart valves IP, it still leaves questions hanging so we do need to hear what they have in mind in these strategic plans.Does the new NOMAD, Stockdale Securities, have an input here into ways of financing such developments? Will Biomerics be involved?Whatever the case, it should be a catalyst for share price movement. | bones | |
12/2/2018 23:35 | Recent statement from company, included in RNS re dispute settlement “We now look forward to focusing on developing AorTech's IP assets." Note do not say, licensing or selling but “developing IP asset” Reasonable to assume developing might cost money, money that AOR may or may not have | magc | |
12/2/2018 22:33 | Couldn't of said it any better Stig.... | k1ngkonggb | |
12/2/2018 19:51 | Does anyone else feel that the forthcoming news will be accompanied by some sort of fund raise to quite possibly implement AOR's plans. Just have a hunch, but believe me I hope I am way off the mark. | cocker | |
12/2/2018 19:50 | turbotrader2 9 Feb '18 - 12:41 - 3893 of 3917 0 0 0 Seriously stig - your research is outstanding and we are grateful do you seriously have a £5 target in a year? great post , ps still in for a win here | petebarnes1 | |
12/2/2018 18:34 | Be careful what you wish forBill was very coy with me on emails | turbotrader2 | |
12/2/2018 17:41 | It was now 2 months ago that the board had conducted a thorough review. The detailed strategic plan was being considered then !! Surely they must be ready soon or maybe that such a big deal is going to be announced that they need time to tie up all the legals !! we can live in hope !! | parsons4 | |
12/2/2018 17:27 | Investor, Defo buys. As bones highlighted, the MMs are up to their usual tricks to get stock. There is very limited amount about. | k1ngkonggb | |
12/2/2018 16:26 | Do you really think so? Odd as share price down today. | investordave | |
12/2/2018 15:05 | Yup mostly buys today | turbotrader2 | |
12/2/2018 14:59 | KKGB, MMs trying a fake on then to get stock? I guess that's possible as stock is scarce :) | bones | |
12/2/2018 14:13 | Don't think that 15k was a sell. Tried a dummy buy and offered very similar price, in fact, slightly cheaper. | k1ngkonggb | |
12/2/2018 12:12 | Well i sure hope you are right Every time i read the past RNSs its clear there is a hello of a lot to play for Let’s see | turbotrader2 | |
12/2/2018 11:40 | Might not be an idiot might just be someone who likes to leave something on the table for the next man. I was very grateful for the sellers at 10p odd. I get sense news is due so would personally be holding on/accumulating right now. The mispriced optionality here is phenomenal. It's no exaggeration to say a 100 bagger is possible here simply by reference to previous chart history and some understanding of the market sizes/opportunities available for Holy Grail tech solutions | the stigologist | |
12/2/2018 11:18 | I see some idiot has just offloaded 15,000 shares. Good riddance. More available now for the rest of us. | investordave | |
12/2/2018 08:14 | Yes, Parsons, AOR seem to have been "unlucky" for a long time!In 2012 they were in court against their biggest customer, St Jude Medical. They got that settled but lost their manufacturing capability so got involved with Biomerics which took ages to set up. Ex-CEO McGuire was in charge of that. Once that deal was done, he immediately left and he was soon alleged of taking IP with him and using it with his new company.Meanwhile two or three customers were not paying their debts so write offs were taken.The biggest issue seems to be that AOR have never had a clear run at managing the business of maximising their IP as they are constantly fighting fires. Hopefully, they can finally focus and get on top of managing IP protection and customer relationships with Biomerics' help. Please let Biomerics be an honest broker!! | bones |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions